Medical Device News Magazine

PROCEPT BioRobotics Appoints Reza Zadno, PhD, as New President and CEO

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • With his remarkable business and technical acumen, we believe he is uniquely qualified to lead the company through rapid expansion and build a market leader in the BPH therapy space,” said Rodney Perkins, MD, co-founder and chairman of the board.

PROCEPT BioRobotics Corporation, a Silicon Valley surgical robotics company developing intelligent solutions to transform the field of urology, has announced the appointment of Reza Zadno, PhD, as its new president and chief executive officer.

With more than three decades of leadership experience in the medical device industry, Zadno brings expertise in leading and scaling commercial operations. He is also an accomplished inventor and medical device company founder with a proven track record of building significant shareholder value.

Zadno joins PROCEPT BioRobotics as it seeks to rapidly expand the global adoption of Aquablation® therapy, performed by the AquaBeam® Robotic System, the first FDA-granted surgical robot for the autonomous removal of prostate tissue in males suffering from benign prostatic hyperplasia (BPH). Aquablation has been awarded both the New Technology Add-on Payment and Transitional Pass-Through Payment from CMS in the United States by demonstrating a substantial clinical improvement compared to other available surgical approaches to BPH.

“We are exceptionally pleased to appoint Reza to CEO at such a pivotal growth time for PROCEPT BioRobotics. With his remarkable business and technical acumen, we believe he is uniquely qualified to lead the company through rapid expansion and build a market leader in the BPH therapy space,” said Rodney Perkins, MD, co-founder and chairman of the board. “PROCEPT’s technology of rapid, precise image-guided tissue removal represents the next generation of surgical robotics, and Reza can lead us into this new era of surgery.”

“Technology has advanced significantly since the development of the earliest robotic platforms used in medicine,” said Frederic Moll, MD, co-founder of Intuitive Surgical and Auris Health Inc. and member of PROCEPT BioRobotics’ board. “PROCEPT BioRobotics is a unique company in the robotics space that has the ability to augment surgical technique utilizing next generation robotic technology.”

Zadno came to PROCEPT BioRobotics after serving as president and CEO of Avedro Inc. (NASDAQ: AVDR), an ophthalmology company that developed a proprietary Corneal Remodeling Platform Technology. While there, he led the company through sizeable fundraising and rapid commercialization, achieving greater than 95 percent coverage from commercial payers. Zadno took the company public in February 2019 and completed an acquisition by Glaukos (NYSE: GKOS) in November 2019.

Prior to his position at Avedro, Zadno spent five years as a venture partner at firms including Interwest Partners and Novartis Fund. Additionally, he was the founder, president and CEO of Visiogen, which was acquired by Abbott Medical Optics (now Johnson & Johnson Vision). Reza earlier co-founded PercuSurge, a maker of distal protection devices used in treating occluded carotid arteries and saphenous vein grafts, which was acquired by Medtronic.

“Surgical robotics is certainly one of the most exciting fields in healthcare, and I am a true believer in PROCEPT BioRobotics’ technology and the global market opportunity that stands before us,” said Zadno. “For the first time, PROCEPT has brought a technology to the market where the robot performs the surgical removal of prostatic tissue. This foundation allows us to now advance surgery even further by incorporating artificial intelligence.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.